IDT Australia soars on upgraded annual earnings forecasts
BUZZ-IDT Australia soars on upgraded annual earnings forecasts ** Shares of IDT Australia IDT.AX rise as much as 35.9% to A$0.044, their highest since April 16
** Stock on track for strongest session since late November 2021, if trend holds; last up 28.1%
** Pharmaceutical manufacturing co upgrades FY26 total revenue forecast to A$20.3 million ($14.2 million) compared with prior forecast of A$18 million to A$19 million
** Adds, expects FY26 EBITDA loss of about A$0.95 million compared with prior forecast of A$1.5 million to A$2 million loss
** Upgrade in full-year forecasts due to strong demand for facilities and drug manufacturing services - co
** Near 682,155 shares trade hands, about twice the 30-day average
** IDT down 19.6% YTD, including session's moves
($1 = 1.4276 Australian dollars)
(Reporting by Subhalakshmi Dey in Bengaluru)
Recent news on IDT Australia
See all newsBrief: IDT Australia Sees Unaudited Fy26 Revenue From Three Verticals To Rise To A$16.8 Million
IDT Australia soars on upgraded annual earnings forecasts
IDT Australia climbs on positive FY26 outlook
Brief: Idt Australia Forecasts FY26 EBITDA Loss Of A$1.5m-A$2m
IDT Australia eyes strongest session in over four years as EBITDA loss narrows